FrancophonIA/ELRC3.0 huggingface dataset:
English: Vaccination: 2 injections of one dose (1 ml) from the age of 56 days, with an interval of 3 weeks between injections.
Estonian: Vaktsineerimine: 2 süsti 1 ml annusega alates 56. elupäevast, 3 nädalase intervalliga süstekordade vahel.
English: 0.1 mg Clear to slightly turbid, reddish to pale-pink coloured suspension.
Estonian: 0,1 mg Selge kuni kergelt hägune punaka kuni kahvaturoosa värvusega suspensioon.
English: In cases of exposure of the sows to antigens (from either field infections and/or vaccination) the antibodies transmitted to the piglets can interfere with active immunisation at 12 weeks of age.
Estonian: Emiste kokkupuutel antigeenidega (kas nakkuslik keskkond ja/või vaktsineerimine) võivad põrsastele ülekanduvad antikehad segada aktiivset immuniseerimist 12. elunädalal.
English: Maternally-derived antibodies in piglets interfere with the RESPIPORC FLUpan H1N1 mediated immunity.
Estonian: Emasloomadelt põrsastele ülekanduvad antikehad segavad RESPIPORC FLUpan H1N1 vahendatud immuunsust.
English: 4.2 Indication for use, specifying the target species
Estonian: 4.2 Näidustused, määrates kindlaks vastavad loomaliigid
English: Pigs.
Estonian: Sead.
English: Neutralising antibodies in serum have been detected in more than 75% of the immunised pigs on day 7 after primary immunisation, lasting in more than 75% of the pigs for over 3 months.
Estonian: Neutraliseerivaid antikehi seerumis on tuvastatud rohkem kui 75% immuniseeritud sigadest 7. päeval pärast esmast immuniseerimist, mis kestis rohkem kui 75% sigadest üle 3 kuu.
English: 25 ml polyethylene terephthalate (PET) vials 50 ml PET vials
Estonian: 25 ml polüetüleentereftalaadi PET viaal 50 ml PET viaal
English: 1 HU - haemagglutinating units.
Estonian: 1 HU - hemaglutineerivad komponendid.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box for 25 ml, 50 ml
Estonian: VÄLISPAKENDIL PEAVAD OLEMA JÄRGMISED ANDMED Pappkarp 25 ml, 50 ml jaoks
English: Active immunisation of pigs from the age of 8weeks onwards against pandemic H1N1 porcine influenza virus to reduce viral lung load and virus excretion.
Estonian: Sigade aktiivne immuniseerimine alates 8. elunädalast pandeemilise H1N1 seagripi viiruse vastu, et vähendada viiruslikku koormust kopsudele ja takistada viiruse levikut.
English: Efficacy of the vaccine was examined in laboratory challenge studies in pigs without maternallyderived antibodies and was demonstrated against the following strains:
Estonian: Vaktsiini tõhusust uuriti sigadel, kellel puudusid emasloomadelt ülekandunud antikehad, ning immuunsus tuvastati järgmiste tüvede suhtes:
English: Bromobutyl rubber stoppers
Estonian: bromobutüülkummist punnkork
English: Duration of immunity: 3 months after primary vaccination.
Estonian: 3 kuud pärast esmast vaktsineerimist.
English: RESPIPORC FLUpan H1N1 suspension for injection for pigs
Estonian: RESPIPORC FLUpan H1N1 süstesuspensioon sigadele
English: The vaccine stimulates an active immunity against pandemic porcine influenza A/Jena/VI5258/2009 (H1N1)pandemic09-like virus.
Estonian: Vaktsiin stimuleerib aktiivset immuunsust pandeemilise seagripi A/Jena/VI5258/2009 (H1N1)pandemic09-sarnase viiruse vastu.
English: Clear to slightly turbid, reddish to pale-pink coloured suspension.
Estonian: Selge kuni kergelt hägune punaka kuni kahvaturoosa värvusega suspensioon.
English: Cardboard box with 1 vial of 25 doses (25 ml) or 50 doses (50 ml) with a rubber stopper and flanged cap.
Estonian: Pappkarp, milles on 1 viaal 25 annusega (25 ml) või 50 annusega (50 ml), suletud kummist punnkorgiga, mida katab äärisega kork.
English: The antibody responses mentioned in the following have been documented in pigs without maternally-derived immunity.
Estonian: Järgnevalt mainitud antikeha reaktsioone on täheldatud ilma emasloomadelt ülekanduva immuunsuseta sigadel.
English: MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Estonian: BIOLOOGILIS(T)E TOIMEAINE(TE) TOOTJA(D) JA RAVIMIPARTII VABASTAMISE EEST VASTUTAV TOOTJA
English: Aluminium flanged caps
Estonian: alumiiniumäärisega kork
English: Inactivated influenza A virus/human, strain A/Jena/VI5258/2009(H1N1)pdm09: ≥ 16 HU
Estonian: Inaktiveeritud A-gripi viirus/inimpäritolu, tüvi A/Jena/VI5258/2009(H1N1)pdm09: ≥ 16 HU
English: PACKAGE LEAFLET FOR: RESPIPORC FLUpan H1N1 suspension for injection for pigs
Estonian: PAKENDI INFOLEHT RESPIPORC FLUpan H1N1 süstesuspensioon sigadele
English: Inactivated influenza A virus/human Strain: A/Jena/VI5258/2009(H1N1)pdm09
Estonian: Inaktiveeritud A-gripi viirus/inimpäritolu Tüvi: A/Jena/VI5258/2009(H1N1)pdm09
English: Haemagglutination-inhibiting antibodies have been detected in 15100% of the immunised pigs on day 7 after primary immunisation which disappeared in the majority of animals within 1 to 4 weeks thereafter.
Estonian: Hemaglutinatsiooni pärssivaid antikehi on tuvastatud 15…100% vaktsineeritud sigadest 7. päeval pärast esmast vaktsineerimist.
English: For intramuscular use.
Estonian: Retseptiravim.
English: Excipient:
Estonian: Punnkork:
English: Caps:
Estonian: Kork:
English: A transient swelling up to 2 cm3 may occur at the site of injection, these reactions are common but resolve within 5 days.
Estonian: Süstekohas võib tekkida mööduv turse mõõtmetega kuni 2 cm3.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vials of 25 ml and 50 ml
Estonian: MINIMAALSED ANDMED, MIS PEAVAD OLEMA VÄIKESEL VAHETUL SISEPAKENDIL
English: The European Commission granted a marketing authorisation valid throughout the European Union for Lantus on 9 June 2000.
Estonian: Euroopa Komisjon andis Lantuse müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 9. juunil
English: Lantus is given once a day.
Estonian: Lantust manustatakse üks kord ööpäevas.
English: The full EPAR for Lantus can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Lantuse kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: In adults (aged 18 years or over), it can be given at any time, provided that it is at the same time each day.
Estonian: Täiskasvanutele (vähemalt 18-aastased) tohib Lantust manustada mis tahes kellaajal, iga päev samal ajal.
English: The full list is available in the package leaflet.
Estonian: Täielik loetelu on pakendi infolehel.
English: EPAR summary for the public insulin glargine
Estonian: Kokkuvõte üldsusele glargiininsuliin
English: Insulin glargine is very slightly different from human insulin.
Estonian: Glargiininsuliin erineb iniminsuliinist väga vähe.
English: Further studies have also been carried out to compare Lantus and human insulin NPH in patients with type 1 diabetes aged between five and 18 years, 200 of whom received Lantus, and in children aged two to six years, 61 of whom received Lantus.
Estonian: Täiendavad uuringud tehti Lantuse ja NPH-iniminsuliini võrdlemiseks 5-18-aastastel I tüüpi diabeediga patsientidel, kellest 200 said Lantust, ja 2-6-aastastel lastel, kellest 61 said Lantust.
English: Reactions at the site of the injection (redness, pain, itching and swelling) and skin reactions (rash) have been seen more often in children than in adults.
Estonian: Süstekoha reaktsioonid (punetus, valulikkus, sügelus ja turse) ja nahareaktsioonid (lööve) esinesid sagedamini lastel kui täiskasvanutel.
English: The CHMP decided that Lantus's benefits are greater than its risks and recommended that it be given marketing authorisation.
Estonian: Inimravimite komitee otsustas, et Lantuse kasulikkus on suurem kui sellega kaasnevad riskid, ja soovitas anda ravimi müügiloa.
English: A total of 2,106 patients received Lantus in all trials combined.
Estonian: Kõigis uuringuis kokku kasutas Lantust 2106 patsienti.
English: It should be given in the evening in patients aged less than 18 years.
Estonian: Alla 18-aastastele patsientidele tuleb Lantust manustada õhtul.
English: For more information about treatment with Lantus, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Lantusega toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: Lantus doses might also need to be adjusted when given with some other medicines that may have an effect on blood glucose levels.
Estonian: Lantuse annuseid võib olla vaja kohandada, kui seda võetakse koos muu ravimiga, mis võib mõjutada vere glükoosisisaldust.
English: Other information about Lantus:
Estonian: Muu teave Lantuse kohta
English: Lantus was originally studied in 10 studies, in both type 1 diabetes (when the pancreas cannot produce insulin) and type 2 diabetes (when the body is unable to use insulin effectively).
Estonian: Lantust uuriti 10 uuringus, nii I tüüpi diabeedi (kõhunäärmes ei teki insuliini) kui ka II tüüpi diabeedi korral (organism ei suuda insuliini efektiivselt kasutada).
English: All of the studies measured the level of ‘fasting' blood glucose (measured when the patients had not eaten for at least eight hours) or a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well blood glucose is controlled.
Estonian: Kõigis uuringuis mõõdeti kas vere glükoosisisaldust tühja kõhu korral (patsient ei olnud söönud vähemalt 8 tundi) või vere glükohemoglobiini (HbA1c) sisaldust, mis näitab, kui hästi organism reguleerib vere glükoosisisaldust.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Lantus.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: Why has Lantus been approved?
Estonian: Miks Lantus heaks kiideti?
English: The most common side effect with Lantus (seen in more than 1 patient in 10) is hypoglycaemia (low blood glucose levels).
Estonian: Lantuse kõige sagedam kõrvalnäht (esinenud enam kui 1 patsiendil 10st) on hüpoglükeemia (vere vähene glükoosisisaldus).
English: Patients can inject themselves with Lantus if they have been trained appropriately.
Estonian: Kui patsiendid on saanud asjakohase väljaõppe, tohivad nad Lantust süstida endale ise.
English: The site of injection should be changed with each injection to avoid changes to the skin (such as thickening) that can make the insulin work less well than expected.
Estonian: Süstekohta peab iga süste korral muutma, et vältida nahamuutusi (nt nahapaksendeid), mis võivad vähendada insuliini toimet.
English: Lantus led to a decrease in the level of HbA1c, indicating that blood glucose levels had been controlled to a similar level to that seen with human insulin.
Estonian: Lantus põhjustas HbA1c sisalduse vähenemist, mis näitas, et ravim reguleeris vere glükoosisisaldust sarnasel määral kui iniminsuliin.
English: The change means that it is absorbed more slowly and regularly by the body after an injection, and that it has a long duration of action.
Estonian: Pärast süstimist imendub insuliinglargiin aeglasemalt ja ühtlasemalt kui iniminsuliin ning tal on pikk toimeaeg.
English: The active substance in Lantus, insulin glargine, is produced by a method known as ‘recombinant DNA technology': it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin glargine.
Estonian: Lantuse toimeainet glargiininsuliini valmistatakse rekombinant-DNA-tehnika abil: glargiininsuliini toodab bakter, millele on lisatud glargiininsuliini teket võimaldav geen (DNA).
English: It is available as vials, cartridges and prefilled disposable pens (OptiSet and SoloStar).
Estonian: Ravimit turustatakse viaalides, kolbampullides ja eeltäidetud ühekordsetes süstaldes (OptiSet ja SoloStar).
English: What is Lantus?
Estonian: Mis on Lantus?
English: Diabetes is a disease in which the body does not produce enough insulin to control the level of blood glucose.
Estonian: Diabeet (suhkurtõbi) on haigus, mille korral ei teki organismis vere glükoosisisalduse reguleerimiseks piisavalt insuliini.
English: Lantus must not be used in people who are hypersensitive (allergic) to insulin glargine or to any of the other ingredients.
Estonian: Lantust ei tohi kasutada patsiendid, kes võivad olla glargiininsuliini või selle ravimi mis tahes muu koostisaine suhtes ülitundlikud (allergilised).
English: Lantus is given by injection under the skin in the abdominal wall (tummy), the thigh, or the deltoid region (shoulder).
Estonian: Lantust süstitakse naha alla kõhuseina, reide või deltalihase piirkonda (õlga).
English: What is the risk associated with Lantus?
Estonian: Mis riskid Lantusega kaasnevad?
English: Studies have also been carried out in nearly 1,400 adults with type 1 or type 2 diabetes to measure the effectiveness of Lantus injected at any time during the day, compared with an injection given in the evening.
Estonian: Uuriti ka ligi 1400 täiskasvanud patsienti, kellel oli I või II tüüpi diabeet, et võrrelda ööpäeva jooksul mis tahes kellaajal ja õhtul süstitud Lantuse efektiivsust.
English: In one study, patients with type 2 diabetes also received antidiabetes medicines by mouth.
Estonian: Ühes II tüüpi diabeedi uuringus said patsiendid ka suukaudseid diabeediravimeid.
English: Lantus is a replacement insulin that is very similar to the insulin made by the body.
Estonian: Lantus on asendusinsuliin, mis on väga sarnane organismis tekkiva insuliiniga.
English: The main studies compared Lantus given once a day at bedtime with human insulin NPH (an intermediate-acting insulin) given once or twice a day.
Estonian: Põhiuuringuis võrreldi kord ööpäevas (enne magamaminekut) manustatavat Lantust NPHiniminsuliiniga (keskpika toimeajaga insuliin), mida manustati üks kord või kaks korda ööpäevas.
English: For the full list of all side effects reported with Lantus, see the package leaflet.
Estonian: Lantuse kohta teatatud kõrvalnähtude täielik loetelu on pakendi infolehel.
English: Injections of fast-acting insulin were also used at mealtimes.
Estonian: Söögiaegadel süstiti ka kiiretoimelist (lühikese toimeajaga) insuliini.
English: Lantus is a solution for injection that contains the active substance insulin glargine.
Estonian: Lantus on süstelahus, mis sisaldab toimeainena glargiininsuliini.
English: This document is a summary of the European Public Assessment Report (EPAR) for Lantus.
Estonian: See on ravimi Lantus Euroopa avaliku hindamisaruande kokkuvõte.
English: Lantus is used to treat diabetes in patients aged two years or older.
Estonian: Lantust kasutatakse vähemalt 2-aastastel patsientidel diabeedi (suhkurtõve) raviks.
English: What is Lantus used for?
Estonian: Milleks Lantust kasutatakse?
English: What benefit has Lantus shown during the studies?
Estonian: Milles seisneb uuringute põhjal Lantuse kasulikkus?
English: The patient's blood glucose (sugar) should be regularly tested to find the lowest effective dose.
Estonian: Väikseima efektiivse annuse leidmiseks peab patsiendi vere glükoosisisaldust regulaarselt kontrollima.
English: The effectiveness of Lantus was seen regardless of the time of the injection.
Estonian: Lantuse efektiivsus ei sõltunud süstimise kellaajast.
English: How is Lantus used?
Estonian: Kuidas Lantust kasutatakse?
English: How has Lantus been studied?
Estonian: Kuidas Lantust uuriti?
English: Lantus was effective in managing diabetes in adults and children aged two years and above.
Estonian: Lantus oli täiskasvanutel ja vähemalt 2-aastaste lastel diabeedi ravis efektiivne.
English: The medicine can only be obtained with a prescription.
Estonian: Lantus on retseptiravim.
English: How does Lantus work?
Estonian: Kuidas Lantus toimib?
English: Lantus can also be given together with antidiabetes medicines taken by mouth in patients who have type 2 diabetes.
Estonian: Patsientidele, kellel on II tüüpi (insuliinisõltumatu) diabeet, tohib Lantust anda koos suukaudsete diabeediravimitega.
English: Wear personal protective equipment.
Estonian: Kandke isikukaitsevahendeid.
English: This did not affect long-term development of colonies.
Estonian: See ei mõjutanud pere pikaajalist arengut.
English: Dosing should be done carefully and overdosing should be avoided.
Estonian: Manustamine peab toimuma ettevaatlikult ja vältima peab üleannustamist.
English: Used measuring devices and empty containers should be disposed of immediately in a proper way.
Estonian: Kasutatud mõõtevahendid ja tühjad mahutid peab asjakohasel viisil kohe hävitama.
English: 27 80689 Munich Germany
Estonian: 80689 Munich Saksamaa
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION <Date of first authorisation:> 01/02/2018
Estonian: ESMASE MÜÜGILOA VÄLJASTAMISE / MÜÜGILOA UUENDAMISE KUUPÄEV <Esmase müügiloa väljastamise kuupäev:> 01/02/2018
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Estonian: Üksikasjalik teave selle veterinaarravimi kohta on Euroopa Ravimiameti koduleheküljel (http://www.ema.europa.eu/).
English: Store away from food.
Estonian: Hoida toidust eraldi.
English: The outside temperature during treatment with Oxybee should be at least 3 °C.
Estonian: Välistemperatuur peab Oxybeega ravi ajal olema vähemalt 3 °C.
English: Shelf life after mixing according to directions: 1 year.
Estonian: Kõlblikkusaeg pärast segamist vastavalt juhendile: 1 aasta.
English: Close the bottle tightly and shake it until the sucrose is completely dissolved.
Estonian: Sulgege pudel korralikult ja loksutage seni, kuni sahharoos on täielikult lahustunud.
English: The overdose did not significantly affect the development of the colonies in the long term, as shown by the development of the colonies in spring.
Estonian: Üleannustamine ei mõjutanud oluliselt pere arengut pika aja jooksul, mida näitab pere areng kevadel.
English: Do not exceed the recommended dose and do not administer this veterinary medicinal product more than once.
Estonian: Ärge ületage soovitatavat annust ega manustage seda veterinaarravimit rohkem kui üks kord.
English: An overdose of 53% of the dispersion per treatment resulted in a temporary, short-term increase in bee mortality.
Estonian: 53-protsendiline dispersiooni üleannustamine ühe ravikorra kohta põhjustas lühiajalist ajutist mesilaste suremuse suurenemist.
English: The total amount of product administered to a colony should not exceed 54 ml.
Estonian: Ühele perele manustatav ravimpreparaadi üldkogus ei tohi ületada 54 ml.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the labels and the cardboard box.
Estonian: Ärge kasutage veterinaarravimit pärast kõlblikkusaega, mis on märgitud etikettidele ja kartongkarbile.
English: In case of eye contact, immediately rinse the eye thoroughly with water (remove contact lenses first).
Estonian: Silma sattumisel loputage silmi kohe põhjalikult veega (esmalt eemaldage kontaktläätsed).
English: Repeated treatments are not well tolerated by bees.
Estonian: Mesilased ei pruugi korduvat ravi hästi taluda.
English: The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this product.
Estonian: Abiained, mis on loetletud ravimi omaduste kokkuvõtte lõigus 6.1, on kas lubatud ained, millele komisjoni määruse (EL) nr 37/2010 lisa tabelis 1 viidatakse kui ravimijääkide piirnorme mittenõudvatele, või määruse (EÜ) nr 470/2009 reguleerimisalasse mittekuuluvad, kui neid kasutatakse nii nagu selles veterinaarravimis.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 colonies treated displaying adverse reaction(s)) - common (more than 1 but less than 10 colonies in 100 colonies treated) - uncommon (more than 1 but less than 10 colonies in 1,000 colonies treated) - rare (more than 1 but less than 10 colonies in 10,000 colonies treated) - very rare (less than 1 colony in 10,000 colonies treated, including isolated reports.
Estonian: Kõrvaltoimete esinemissagedus on defineeritud järgnevalt: - väga sage (kõrvaltoime(d) ilmnes(id) rohkem kui 1-l perel 10st ravitud perest) - sage (rohkem kui 1-l, kuid vähem kui 10-l perel 100st ravitud perest) - aeg-ajalt (rohkem kui 1-l, kuid vähem kui 10-l perel 1000st ravitud perest) - harv (rohkem kui 1-l, kuid vähem kui 10-l perel 10 000st ravitud perest) - väga harv (vähem kui 1-l perel 10 000st ravitud perest, kaasa arvatud üksikjuhud)
English: In case of accidental ingestion, clean the mouth with water and drink water or milk, but do not induce vomiting.
Estonian: Juhuslikul allaneelamisel loputage suu veega ja jooge vett või piima, kuid ärge kutsuge esile oksendamist.
English: Oxalic acid dihydrate is externally distributed on the bees through body contact and/or social food exchange (trophallaxis).
Estonian: Oksaalhappe dihüdraat jaotub mesilastele kehalise kontakti kaudu ja/või sotsiaalse toiduvahetuse (trofallaksise) kaudu.
English: In case the final dispersion had been stored, it should be well shaken before use.
Estonian: Kui valmisdispersioon on seisnud, tuleb seda enne kasutamist korralikult loksutada.
English: The active substance in Oxybee is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Estonian: C. RAVIMJÄÄKIDE PIIRNORMID Oxybee toimeaine on komisjoni määruse (EL) nr 37/2010 lisa tabelis 1 kirjeldatud lubatud aine.
English: OTHER INFORMATION
Estonian: MUU TEAVE
English: Honey: Zero days.
Estonian: Mesi: null päeva.
English: If worker bees are treated more than once per generation, it can result in damage to the bees and a reduction in strength of the colony.
Estonian: Kui ühe pere töömesilasi ravitakse rohkem kui üks kord, võib see mesilasi kahjustada ja põhjustada pere tugevuse vähenemist.
English: Example of measuring device
Estonian: Mõõtmisvahendi näide
English: The veterinary medicinal product should not enter water courses as this may be dangerous for fish and other aquatic organisms.
Estonian: Veterinaarravim ei tohi sattuda veekogudesse, sest võib olla ohtlik kaladele ja teistele veeorganismidele.
English: MANUFACTURER'S BATCH NUMBER Lot {number}
Estonian: TOOTJAPOOLNE PARTII NUMBER Partii number
English: For the full list of excipients, see section 6.1
Estonian: Abiainete täielik loetelu on esitatud lõigus 6.1
English: Studies on the mode of action of oxalic acid are not available.
Estonian: Uuringuid oksaalhappe toimemehhanismi kohta ei ole.
English: Wash hands and exposed skin with soap and plenty of water immediately.
Estonian: Nahale sattumisel peske käed ja saastunud nahk kohe seebi ja rohke veega.
English: Remove contaminated clothing immediately.
Estonian: Eemaldage saastunud kaitseriietus kohe.
English: The concomitant use of other acaricidal products should be avoided because increased toxicity to bees might occur.
Estonian: Vältida tuleb teiste akaritsiidide samaaegset kasutamist, sest see võib suurendada toksilisust mesilastele.
English: Do not eat, drink or smoke whilst handling and applying the veterinary medicinal product.
Estonian: Veterinaarravimi käsitsemise ja kasutamise ajal ärge sööge, jooge ega suitsetage.
English: Disposal: read package leaflet.
Estonian: Hävitamine: vt pakendi infoleht.
English: The use of Oxybee with the above dosing scheme only applies to hives with vertical frames that can be accessed from the top, as the treatment of bees in other types of hives has not been investigated.
Estonian: Oxybee eespool toodud annustamisskeem kehtib ainult ülalt ligipääsetavate vertikaalsete kärgedega tarude kohta, sest mesilaste ravi muud tüüpi tarudes ei ole uuritud.
English: Avoid disturbing the hives in the days following treatment.
Estonian: Vältige tarude häirimist ravile järgnevatel päevadel.